Copyright
©The Author(s) 2025.
World J Exp Med. Sep 20, 2025; 15(3): 107711
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107711
Published online Sep 20, 2025. doi: 10.5493/wjem.v15.i3.107711
Table 1 Characteristics of the included control, benign, and ovarian cancer patients (malignant cases), n (%)
| Variables | Control (n = 30) | Benign (n = 10) | Malignant (n = 50) | |
| Age (years) | mean ± SD | 48.4 ± 8 | 50.7 ± 8.3 | 52.3 ± 14.5 |
| Median (range) | 49 (23-54) | 48.5 (41-66) | 50.5 (25-86) | |
| Family history | Positive | 1(10.0) | 6 (12.0) | |
| Negative | 9 (90.0) | 44 (88.0) | ||
| Metastasis | Positive | 34 (68.0) | ||
| Negative | 16 (32.0) | |||
| Site of metastasis | Omentum/peritoneum | 29 (58.0) | ||
| Ileum | 1 (2.0) | |||
| Ileum and rectum | 1 (2.0) | |||
| Pancreas | 1 (2.0) | |||
| Liver | 1 (2.0) | |||
| Lymph nodes | 1 (2.0) | |||
| Tumor markers | Carcinoembryonic antigen | 65.6 (3.34-116.2) | ||
| CA19-9 | 475.95 (41.3-7174) | |||
| CA15-3 | 47.25 (27.39-353.3) | |||
- Citation: Ibrahim NH, Abdellateif MS, Serag DS, Laymouna A, Elaguizy MS, Halim RMA. Clinical significance of differential plasma proteins levels in the diagnosis of epithelial ovarian cancer. World J Exp Med 2025; 15(3): 107711
- URL: https://www.wjgnet.com/2220-315X/full/v15/i3/107711.htm
- DOI: https://dx.doi.org/10.5493/wjem.v15.i3.107711